Skip to main content

Elevance Health, Inc. income statement

  • ELV · NYSE
  • Insurance
  • Managed Health Care
  • S&P 500
$429.69−0.05%Close 13 Nov 2026 · Market value $96.13B

Elevance Health, Inc. reported revenue of $199.1 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 12.5% from fiscal 2024. Net income was $5.66 billion and diluted earnings per share $25.21.

From Elevance Health, Inc.'s annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Elevance Health, Inc. income statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$61.17B$61.25B$64.94B$58.70B$60.71B$61.50B$71.02B$73.87B$79.16B$84.86B$90.04B$92.11B$104.2B$121.9B$138.6B$156.6B$171.3B$177.0B$199.1B$201.8B
Revenue growth—+0.1%+6.0%−9.6%+3.4%+1.3%+15.5%+4.0%+7.2%+7.2%+6.1%+2.3%+13.1%+16.9%+13.8%+13.0%+9.4%+3.3%+12.5%—
Selling, general and administrative$8.70B$8.50B$9.02B$8.73B$8.44B$8.68B$9.95B$11.75B$12.53B$12.56B$12.65B$14.02B$13.36B$17.45B$15.92B$17.70B$20.09B$20.02B$20.98B$23.04B
Operating income$5.71B$4.35B$7.85B$4.08B$3.78B$3.62B$4.00B$4.42B$4.75B$4.80B$4.17B$5.43B$6.00B$6.36B$7.56B$8.28B$8.50B$7.86B$7.20B$5.43B
Operating margin9.3%7.1%12.1%6.9%6.2%5.9%5.6%6.0%6.0%5.7%4.6%5.9%5.8%5.2%5.5%5.3%5.0%4.4%3.6%2.7%
Interest expense$447.9M$469.8M$447.4M$418.9M$430.3M$511.8M$602.7M$600.7M$653.0M$723.0M$739.0M$753.0M$746.0M$784.0M$798.0M$851.0M$1.03B$1.19B$1.40B$1.45B
Income before tax$5.26B$3.12B$7.40B$4.35B$3.96B$3.86B$3.84B$4.37B$4.63B$4.55B$3.96B$5.07B$5.99B$6.24B$8.00B$7.60B$7.71B$7.90B$6.71B$6.25B
Income tax expense$1.91B$631.7M$2.66B$1.47B$1.31B$1.21B$1.21B$1.81B$2.07B$2.08B$121.0M$1.32B$1.18B$1.67B$1.85B$1.71B$1.72B$1.93B$1.05B$1.15B
Effective tax rate36.4%20.2%35.9%33.7%33.1%31.3%31.4%41.4%44.7%45.8%3.1%26.0%19.7%26.7%23.1%22.5%22.3%24.5%15.6%18.4%
Net income$3.35B$2.49B$4.75B$2.89B$2.65B$2.66B$2.49B$2.57B$2.56B$2.47B$3.84B$3.75B$4.81B$4.57B$6.16B$5.89B$5.99B$5.98B$5.66B$5.14B
Net margin5.5%4.1%7.3%4.9%4.4%4.3%3.5%3.5%3.2%2.9%4.3%4.1%4.6%3.8%4.4%3.8%3.5%3.4%2.8%2.5%
EPS · diluted$5.56$4.76$9.88$6.94$7.25$8.18$8.20$8.99$9.38$9.21$14.35$14.19$18.47$17.98$24.95$24.28$25.22$25.68$25.21$23.42
Diluted weighted average shares602M523M481M416M365M325M304M286M273M268M268M264M260M254M247M243M237M233M225M219M
Basic weighted average shares—520M476M411M360M322M299M276M263M263M262M258M256M251M244M240M236M232M224M219M
EBITDA$6.12B$4.74B$8.22B$4.42B$4.12B$3.96B$4.35B$4.75B$5.09B$5.10B$4.46B$6.56B$7.13B$7.51B$8.86B$9.96B$10.24B$9.26B$8.74B$6.92B
EBITDA margin10.0%7.7%12.7%7.5%6.8%6.4%6.1%6.4%6.4%6.0%4.9%7.1%6.8%6.2%6.4%6.4%6.0%5.2%4.4%3.4%
Depreciation & amortization$410.9M$391.5M$373.1M$344.8M$335.1M$340.1M$353.2M$327.4M$335.9M$296.0M$280.0M$1.13B$1.13B$1.15B$1.30B$1.68B$1.75B$1.39B$1.55B$1.49B
Stock-based compensation$177.1M$156.0M$153.6M$136.0M$134.8M$146.5M$146.0M$168.9M$148.2M$165.0M$170.0M$226.0M$294.0M$283.0M$255.0M$264.0M$289.0M$191.0M$276.0M$240.0M
Dividends per share———$0.00$1.00$1.15$1.50$1.75$2.50$2.60$2.70$3.00$3.20$3.80$4.52$5.12$5.92———

Quarterly

Elevance Health, Inc. income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$42.65B$42.58B$43.89B$45.11B$45.44B$48.89B$49.78B$50.71B$49.75B$50.18B$50.47B$51.43B
Selling, general and administrative$5.00B$4.89B$5.07B$5.27B$4.80B$5.30B$5.00B$5.27B$5.42B$6.33B$5.55B$5.75B
Operating income$1.28B$3.02B$2.77B$1.41B$673.0M$3.17B$2.42B$1.29B$309.0M$2.09B$1.76B$1.27B
Operating margin3.0%7.1%6.3%3.1%1.5%6.5%4.9%2.6%0.6%4.2%3.5%2.5%
Interest expense$259.0M$265.0M$280.0M$300.0M$340.0M$344.0M$341.0M$351.0M$366.0M$357.0M$364.0M$358.0M
Income before tax$1.00B$2.94B$2.99B$1.37B$606.0M$2.80B$2.29B$1.41B$215.0M$2.30B$1.94B$1.79B
Income tax expense$170.0M$690.0M$685.0M$365.0M$193.0M$613.0M$548.0M$219.0M−$331.0M$544.0M$483.0M$451.0M
Effective tax rate17.0%23.5%22.9%26.6%31.8%21.9%23.9%15.6%−154%23.6%24.9%25.1%
Net income$856.0M$2.25B$2.30B$1.02B$418.0M$2.18B$1.74B$1.19B$547.0M$1.76B$1.46B$1.36B
Net margin2.0%5.3%5.2%2.3%0.9%4.5%3.5%2.3%1.1%3.5%2.9%2.7%
EPS · diluted$3.63$9.59$9.85$4.36$1.81$9.61$7.72$5.32$2.47$8.00$6.71$6.27
Diluted weighted average shares236M234M233M233M231M227M226M224M222M220M218M218M
Basic weighted average shares234M233M232M232M230M226M225M223M221M220M217M217M
EBITDA$1.71B$3.35B$3.10B$1.74B$1.07B$3.54B$2.81B$1.68B$715.0M$2.44B$2.13B$1.63B
EBITDA margin4.0%7.9%7.1%3.9%2.4%7.2%5.6%3.3%1.4%4.9%4.2%3.2%
Depreciation & amortization$424.0M$331.0M$335.0M$329.0M$398.0M$373.0M$380.0M$387.0M$406.0M$354.0M$366.0M$363.0M
Stock-based compensation$72.00M$62.00M$92.00M$66.00M−$29.00M$81.00M$81.00M$84.00M$30.00M$55.00M$75.00M$80.00M
Dividends per share$1.48$1.63$1.63$1.63—$1.71$1.71$1.71—$1.72$1.72$1.72

The main figures as JSON and plain text. See data and methodology.

ELV in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.